Whitehawk Therapeutics WHWK Cash Flow Statement (2010-2026)

NASDAQ WHWK
$4.60 -0.03 (-0.65%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Whitehawk Therapeutics Quarterly Cash Flow Statement

Periods 64 quarters
Latest Jun 2026

Whitehawk Therapeutics reported cash from operations of -$14.53M and free cash flow of -$14.37M for the quarter ended Jun 2026, up 72.6% year over year. This cash flow statement covers 64 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-87.09M-15.99M-13.86M-18.27M-14.47M-13.91M-15.22M-17.97M-16.30M-16.27M-19.61M-15.66M-12.54M-18.27M73.02M-52.62M-17.70M-23.28M-22.19M-16.64M
Share-based Compensation
1.30M1.38M2.03M2.23M2.76M2.87M2.74M3.05M3.05M3.11M3.59M2.84M2.56M1.85M1.68M7.59M7.51M2.39M8.24M11.13M
Cash from Operations
-17.37M-12.43M-19.41M-10.72M-8.20M-11.31M-21.31M-16.76M-11.95M-9.64M-19.65M-9.16M-15.69M-15.05M-11.86M-52.96M-15.38M-17.23M-22.21M-14.53M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
1.20M0.86M0.59M0.49M0.42M0.39M0.31M0.18M-0.02M-0.00M0.72M0.83M0.35M0.36M
Amortization of Deferred Charges
-0.15M-1.07M-0.59M-0.49M
Depreciation & Amortization (CF)Depreciation & Amortization
0.03M0.07M0.07M0.03M0.01M0.05M0.04M0.04M0.04M0.04M0.05M
Change in Working Capital
Change in Receivables
2.71M-0.65M0.20M-0.40M3.70M-1.89M2.04M-0.23M-0.56M0.99M0.62M-0.64M1.00M
Change in Inventory
0.20M0.53M0.01M1.13M1.94M-0.58M-0.32M2.23M-0.49M0.16M-0.63M-0.16M-0.17M
Change in Account Payables
0.15M
Change in Accured Expenses
-9.76M0.15M-4.13M1.02M5.03M1.30M-1.54M-5.13M1.72M4.82M-6.76M2.50M-6.10M0.59M0.97M-2.71M0.98M4.67M-3.49M0.03M
Other Working Capital Changes
0.41M1.64M0.58M-0.06M1.05M-0.12M0.64M-1.49M-1.73M-1.03M-0.95M-1.47M-0.18M-0.21M-0.77M-0.14M0.82M0.52M-1.47M-0.76M
Investing Activities
Capital Expenditures
-0.43M-0.05M-0.12M-0.16M0.65M0.08M1.37M0.69M1.10M0.82M0.74M0.54M0.19M0.19M0.55M0.21M-0.17M-0.05M-0.16M-0.16M
Divestments
101.36M-0.07M
Change in Acquisitions & Divestments
12.75M40.75M51.25M41.26M18.36M18.94M15.88M15.20M13.32M14.69M3.39M2.00M39.76M38.62M33.77M
Cash from Investing Activities
25.36M-0.05M-0.02M-0.24M-48.24M-84.38M16.33M50.56M12.67M3.65M10.55M-3.57M5.08M13.13M115.50M-28.83M-91.63M16.85M19.43M-16.87M
Financing Activities
Other financing activities
0.74M0.09M0.24M0.14M0.02M0.01M0.01M0.29M0.11M0.01M0.08M0.05M0.02M0.06M0.09M
Debt Issuance and Repayment
Long-Term Debt Issuances
Change in Capital Stock
Net Shares Issued and Repurchased
0.67M1.25M0.35M4.04M0.14M
Net Equity Issued and Repurchased
Misc.
Cash from Financing Activities
141.72M0.09M0.30M-0.09M72.52M-0.11M0.01M0.31M-0.07M0.08M-0.01M0.09M0.05M95.20M-0.85M0.03M81.84M
Change in Cash
149.70M-12.39M-19.14M-11.05M16.08M-95.80M-4.97M34.12M0.64M-5.92M-9.11M-12.64M-10.60M-1.87M198.84M-82.63M-107.00M-0.36M-2.78M50.44M
Free Cash Flow
-16.94M-12.38M-19.29M-10.56M-8.85M-11.39M-22.68M-17.45M-13.05M-10.46M-20.39M-9.70M-15.88M-15.24M-12.41M-53.17M-15.21M-17.18M-22.05M-14.37M
Net Cash Flow
149.70M-12.39M-19.14M-11.05M16.08M-95.80M-4.97M34.12M0.64M-5.92M-9.11M-12.64M-10.60M-1.87M198.84M-82.63M-107.00M-0.36M-2.78M50.44M